Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by AgeX Therapeutics, Inc. AgeX Therapeutics Reports Third Quarter 2023 Financial Results November 14, 2023 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement August 30, 2023 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports Second Quarter 2023 Financial Results August 14, 2023 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock July 24, 2023 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock July 21, 2023 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Announces Appeal of NYSE American Determination May 23, 2023 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports First Quarter 2023 Financial Results May 12, 2023 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results March 31, 2023 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements November 25, 2022 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports Third Quarter 2022 Financial Results November 10, 2022 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports Second Quarter 2022 Financial Results August 12, 2022 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors May 18, 2022 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports First Quarter 2022 Financial Results May 13, 2022 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results March 29, 2022 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders December 14, 2021 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001 November 30, 2021 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports Third Quarter 2021 Financial Results November 12, 2021 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics Reports Second Quarter 2021 Financial Results August 13, 2021 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE AgeX Therapeutics and LyGenesis Terminate Merger Negotiations July 23, 2021 From AgeX Therapeutics, Inc. Via Business Wire Tickers AGE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.